Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A compassionate use program of SM-88

Trial Profile

A compassionate use program of SM-88

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 12 Jun 2018

At a glance

  • Drugs SM 88 (Primary)
  • Indications Breast cancer; Colon cancer; Glioma; Lymphoma; Ovarian cancer; Pancreatic cancer; Prostate cancer; Sarcoma
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 12 Jun 2018 Details data and results of analyses from first-in-human phase I study (CT profiles 700255130) and this compassionate use study (n=83) presented in a Tyme Technologies media release.
    • 22 Jan 2018 New trial record
    • 20 Jan 2018 Results of a retrospective analysis of 12 patients with advanced or metastatic pancreatic cancer from this and the phase 1 study, presented at the 2018 Gastrointestinal Cancers Symposium
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top